Amarantus to Present at LD Micro Main Event on Dec
Post# of 30028
Download as PDF
DECEMBER 03, 2015
SAN FRANCISCO, December 3, 2015 /PRNewswire/ --
Amarantus Bioscience Holdings, Inc. (OTCQX:AMBS), a biotechnology company developing therapeutic and diagnostic product candidates in orphan indications and neurology, announced today that the Company will be presenting at the 8th Annual LD Micro Main Event. The conference will be held December 1-3 at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Gerald E. Commissiong, President and CEO of Amarantus, will present on Thursday, December 3, 2015 at 10:30 am Pacific Time.
The Company's presentation will be available for the public to access at http://wsw.com/webcast/ldmicro9/ambs. This webcast will be archived for 90 days following the live presentation.
About LD MICRO
LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Invitational. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit http://www.ldmicro.com .